Please use this identifier to cite or link to this item:
https://hdl.handle.net/20.500.12530/29981| Title: | Switching biological disease-modifying antirheumatic drugs in patients with axial spondyloarthritis: results from a systematic literature review. | |
| Authors: | ||
| Keywords: | ||
| Issue Date: | 2017 | |
| Citation: | RMD Open.2017;(3)2:e000524 | |
| Abstract: | First, to investigate if switching biological disease-modifying antirheumatic drugs (bDMARDs) after the failure to prior bDMARD is efficacious in patients with axial spondyloarthritis (axSpA). Second, to evaluate the influence on this efficacy of (1) the reason to discontinue prior tumour necrosis factor inhibitor (TNFi), (2) changing the type of TNFi and (3) changing the target. | |
| PMID: | 29071119 | |
| URI: | https://hdl.handle.net/20.500.12530/29981 | |
| Rights: | openAccess | |
| ISSN: | 2056-5933 | |
| Appears in Collections: | Fundaciones e Institutos de Investigación > IIS H. U. La Paz > Artículos Hospitales > H. U. La Paz > Artículos | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| PMC5640114.pdf | 559.08 kB | Adobe PDF |  View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.